Newsletter January 2026
Join us at EPO's Spring Meeting 2026
Dear Colleagues, Friends and Companions,
The EPO team cordially invites you to the 5th EPO Spring Meeting, which will take place on May 20, 2026 at the historic Berlin-Brandenburg Academy of Sciences and Humanities.
Continuing the tradition of this symposium, we will once again provide a forum for scientists, clinicians, and industry professionals to exchange current research findings and discuss key challenges and developments in cancer modelling.
An excellent line-up of scientific speakers will present recent advances across multiple areas of preclinical and translational research, including:
- Pediatric oncology: Anton Henssen (ECRC, Charité / MDC)
- Antibody–drug conjugates: Svea Becker (Tubulis)
- Targeted and personalized chemotherapy: Ana Pérez-López (TU Berlin)
- Novel CAR cell therapies: Niels von Wardenburg (Charité)
- Targeted radiotherapeutics: Urs Hagemann (Bayer)
Please refer to the scientific program for further details.
A coffee break and a joint lunch, accompanied by a view over the Gendarmenmarkt, will be included as networking opportunities alongside the scientific sessions.
As space is limited, please register now with Katja Bolle. We look forward to seeing you in Berlin on May 20th!
Best wishes,
Jens Hoffmann, Wolfgang Walther & Antje Wengner
Confirmed speakers are:
- Prof. Dr. Anton Henssen – ECRC, Charité Berlin / Max Delbrück Center
- Dr. Svea Becker – Tubulis GmbH
- Dr. Ana Maria Pérez López – TU Berlin
- Dr. Niels von Wardenburg – Charité Berlin
- Dr. Urs Hagemann – Bayer AG
- Dr. Lars Winkler – EPO Berlin
- Dr. Maria Stecklum – EPO Berlin
- Dr. Diana Daberkow – EPO Berlin